Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products 2022-07-05 08:30
Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia 2022-07-04 22:14
Abbisko Therapeutics Completed Dosing of First Patient for Its First-in-Class Highly Selective FGFR2/3 Inhibitor ABSK061 2022-07-04 13:34
ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer 2022-07-01 22:00
Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918 2022-06-30 10:41
iNtRON to Seek a New Clinical Partner for SAL200 Endolysin 2022-06-28 21:00
Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application 2022-06-26 08:00
Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D 2022-06-25 08:00
Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for idiopathic pulmonary fibrosis 2022-06-24 21:00
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy 2022-06-23 23:00
Viva Biotech Successfully Held The 3rd Annual Partnership Summit 2022-06-23 20:30
I-Mab Receives Top Rankings in Five Categories by Institutional Investor 2022-06-23 20:00
Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials 2022-06-23 09:00
Scientists take the first step to master an all-powerful cell type in the beginning of life 2022-06-21 23:10
Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin's Lymphoma 2022-06-20 20:00
2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines 2022-06-19 10:30
2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines 2022-06-19 10:30
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER 2022-06-17 20:00
WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies 2022-06-16 08:00
I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210 2022-06-15 22:37
1 77 78 79 80 81 222